GlucoTrack, Inc. - Common Stock (GCTK)
0.1678
-0.0075 (-4.28%)
NASDAQ · Last Trade: May 2nd, 12:08 PM EDT
Detailed Quote
Previous Close | 0.1753 |
---|---|
Open | 0.1650 |
Bid | 0.1670 |
Ask | 0.1678 |
Day's Range | 0.1650 - 0.1734 |
52 Week Range | 0.1313 - 79.00 |
Volume | 1,689,928 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 4,911,239 |
Chart
About GlucoTrack, Inc. - Common Stock (GCTK)
GlucoTrack, Inc. is a healthcare technology company focused on the development of innovative non-invasive glucose monitoring solutions for individuals with diabetes. The company leverages advanced sensing technologies to create devices that enable users to track their blood glucose levels without the need for traditional fingerstick methods. GlucoTrack aims to improve the quality of life for diabetic patients by providing them with more convenient and accessible ways to manage their condition, while also enabling healthcare providers to better monitor patient health. Through its commitment to research and development, GlucoTrack seeks to contribute to more effective diabetes management and enhance overall patient outcomes. Read More
News & Press Releases
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · April 30, 2025
Via Benzinga · April 30, 2025
Let's have a look at what is happening on the US markets before the opening bell on Wednesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · April 30, 2025
Via Benzinga · April 30, 2025
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today.
Via Chartmill · April 29, 2025
Via Benzinga · April 29, 2025
Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes study
By Glucotrack, Inc. · Via GlobeNewswire · April 16, 2025
Next Generation AI-Driven Analytics to Unlock Key Insights from the Ongoing Continuous Blood Glucose Monitoring Clinical Study Data
By Glucotrack, Inc. · Via GlobeNewswire · April 3, 2025
Via Benzinga · April 1, 2025
As the regular session of the US market concludes on Friday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via Chartmill · March 28, 2025
Via Benzinga · March 28, 2025
Via Benzinga · March 27, 2025
Via Benzinga · March 25, 2025
Via Benzinga · March 24, 2025
Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.
Via Stocktwits · March 23, 2025
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · March 21, 2025
Let's have a look at what is happening on the US markets on Friday. Below you can find the most active stocks in today's session.
Via Chartmill · March 21, 2025
These stocks have an unusual volume in today's session
Via Chartmill · March 21, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · March 21, 2025
Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · March 21, 2025
Via Benzinga · March 21, 2025
Via Benzinga · March 21, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · March 20, 2025
Via Benzinga · March 20, 2025